Startup Funding News

New startup rounds, lead investors and the businesses behind the funding.

· RoundOS Funding
CSV
Filters & sort
Reset

54 rounds · $4.8B disclosed · $33.4M median

Startup funding rounds
CompanyAmountStage / sectorLead investorAnnounced
Isomorphic Labs

UK-based AI-first drug design and development company.

$2.1BSeries B
Healthtech
Thrive Capital
ALP Bio AG

to accelerate their platform which combines human immune organoid biology with generative AI to help antibody developers identify, understand, and reduce immunogenicity risk earlier in drug development.

€1.9MPre-seed
Healthtech
—
auryx

auryx is on a mission to create the world’s best foundation model for turning sound into health insights.

$2MPre-seed
Healthtech
—
Hypervision Surgical

Hypervision Surgical develops computer-assisted tissue analysis tools for surgeons.

£17MSeries A
Healthtech
—
mbiomics

mbiomics develops microbiome analysis technology to inform targeted therapies.

€12MSeries A
Healthtech
—
Primogene

Leipzig-based BioTech startup enabling the sustainable and scalable manufacturing of complex, high-value molecules.

€4.1MSeed
Healthtech
—
tacalyx

Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA.

€11MSeed
Healthtech
—
TietAI

the Spanish company's goal is to transform the technological foundation on which hospitals operate.

€2.5MSeed
Healthtech
—
dehaze

Munich-based healthtech AI company.

€3.2MSeed
Healthtech
—
Cerca Magnetics

UK-based MedTech startup developing wearable brain imaging systems using quantum sensing technology.

€4.3MSeries A
Healthtech
—
Storm Therapeutics

A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer.

$56MSeries C+
Healthtech
—
Oxford Medical Simulation

Virtual reality (VR) training platform for healthcare professionals.

€5.8MGrowth
Healthtech
—
Vitestro

Utrecht, Netherlands-based developer of an autonomous blood drawing device.

$70MSeries B
Healthtech
—
Polares Medical

Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.

$50MSeries C+
Healthtech
—
Oska Health

a hybrid care provider combining personal health coaches with AI.

€11MSeed
Healthtech
—
nyra health

digital therapy platform for neurological patients.

€20MSeries A
Healthtech
—
Turbine

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

$25MSeries B
Healthtech
—
Centauri

immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic areas.

£30MSeries A
Healthtech
—
Patientdesk.ai

Proven in dental scheduling, now expanding to insurance, payments, and care coordination. Already live across 35+ locations with 3 major chains while building.

$1MPre-seed
Healthtech
—
Neurent Medical

the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis.

€62.5MSeries C+
Healthtech
—
Aerska

Aerska has developed an antibody-oligonucleotide conjugate (AOC) platform that uses “brain shuttles” to help deliver RNAi directly to the brain, allowing for better uptake by neurons and lasting gene knockdown.

$39MSeries A
Healthtech
—
Biorce

a TechBio company focused on transforming clinical trials through artificial intelligence.

$52MSeries A
Healthtech
—
Automata Technologies

Biotech company that offers robotic automation solutions to life sciences labs.

$45MSeries C+
Healthtech
—
Evaro

A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions.

$25MSeries A
Healthtech
—
Altavo

Giving voiceless people an individual, natural sounding voice.

€3MSeries A
Healthtech
—

UK-based AI-first drug design and development company.

Series B · Healthtech
Thrive Capital
ALP Bio AG€1.9M

to accelerate their platform which combines human immune organoid biology with generative AI to help antibody developers identify, understand, and reduce immunogenicity risk earlier in drug development.

Pre-seed · Healthtech

auryx is on a mission to create the world’s best foundation model for turning sound into health insights.

Pre-seed · Healthtech

Hypervision Surgical develops computer-assisted tissue analysis tools for surgeons.

Series A · Healthtech
mbiomics€12M

mbiomics develops microbiome analysis technology to inform targeted therapies.

Series A · Healthtech
Primogene€4.1M

Leipzig-based BioTech startup enabling the sustainable and scalable manufacturing of complex, high-value molecules.

Seed · Healthtech
tacalyx€11M

Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA.

Seed · Healthtech
TietAI€2.5M

the Spanish company's goal is to transform the technological foundation on which hospitals operate.

Seed · Healthtech
dehaze€3.2M

Munich-based healthtech AI company.

Seed · Healthtech

UK-based MedTech startup developing wearable brain imaging systems using quantum sensing technology.

Series A · Healthtech

A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer.

Series C+ · Healthtech

Virtual reality (VR) training platform for healthcare professionals.

Growth · Healthtech

Utrecht, Netherlands-based developer of an autonomous blood drawing device.

Series B · Healthtech

Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.

Series C+ · Healthtech

a hybrid care provider combining personal health coaches with AI.

Seed · Healthtech

digital therapy platform for neurological patients.

Series A · Healthtech

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

Series B · Healthtech

immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic areas.

Series A · Healthtech

Proven in dental scheduling, now expanding to insurance, payments, and care coordination. Already live across 35+ locations with 3 major chains while building.

Pre-seed · Healthtech

the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis.

Series C+ · Healthtech
Aerska$39M

Aerska has developed an antibody-oligonucleotide conjugate (AOC) platform that uses “brain shuttles” to help deliver RNAi directly to the brain, allowing for better uptake by neurons and lasting gene knockdown.

Series A · Healthtech
Biorce$52M

a TechBio company focused on transforming clinical trials through artificial intelligence.

Series A · Healthtech

Biotech company that offers robotic automation solutions to life sciences labs.

Series C+ · Healthtech
Evaro$25M

A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions.

Series A · Healthtech
Altavo€3M

Giving voiceless people an individual, natural sounding voice.

Series A · Healthtech
02 / Perspective

Reports & briefings

monthly briefing

September 2026 Startup Funding Report

49 funding rounds and $6.6B disclosed. Mistral AI leads the edition; explore the companies, investors and stage breakdown.

03 / Investors

Active investors

Explore investors
Investor activity in the selected funding rounds
InvestorRoundsLedRecent investments
01General Catalyst131DwellyNeko Health
02Balderton Capital121SpottThe Exploration Company
03Y Combinator120SpottConveo
04British Business Bank110Certain EnergyAlchemab Therapeutics